Jan Cools
@jancools.bsky.social
96 followers 22 following 15 posts
Leukemia researcher VIB-KULeuven, Editor-in-chief of HemaSphere
Posts Media Videos Starter Packs
jancools.bsky.social
Looking forward to this exciting meeting and to represent @hemasphere-journal.bsky.social in this session!
ndlrconference.bsky.social
We are excited to announce our new #NDLR2026 Meet-the-Editor session, with Editors-in-Chief, Prof Andrew Roberts, @bloodjournals.hematology.org and Prof @jancools.bsky.social, @hemasphere-journal.bsky.social who will share their invaluable insights on #publishing in high-impact #hematology journals.
jancools.bsky.social
Great mix of art & science at the Art Science Museum in Singapore.
Reposted by Jan Cools
hemasphere-journal.bsky.social
In this study the authors show how cancer associated fibroblasts and their spatial architecture in the tumor microenvironment impact survival in patients with cHL. 

Read more about it here 👉https://bit.ly/4mdhPK6
jancools.bsky.social
Exciting to share the new impact factor of @hemasphere-journal.bsky.social, the #openaccess journal of the European Hematology Association (EHA).
The 2024 Journal Impact Factor is 14.6 - ranking as number 5 of 99 hematology journals (Source: Journal Citations Reports, Clarivate).
Reposted by Jan Cools
hemasphere-journal.bsky.social
🚨Today! @ 15:45, MiCo room CORAL 6 
We warmly invite you to the HemaSphere Scientific Session where we will dive into 3 of our exciting + cutting-edge biology publications. Hope to see you there!
🕰️: 15:45 - 16:45
📍: Room CORAL 6, #EHA2025
🎤: https://bit.ly/4koLwXk
jancools.bsky.social
Thank you so much, Charley !
jancools.bsky.social
Thank you Marlies !!
jancools.bsky.social
Thank you EHA, for honoring me with the Education and Mentoring Award. Thank you Peter Marynen and Gary Gilliland for being such inspiring mentors to me! Thank you to all my trainees, all current and past members of my research group. #EHA2025 @hemasphere-journal.bsky.social
Reposted by Jan Cools
hemasphere-journal.bsky.social
Heading to #EHA2025 in Milan in 1.5(ish) weeks? HemaSphere has 2 exciting sessions on the program!
📌Peer Review Workshop: Fri 13 June, 13:30 - 15:00
💡Learn + master the peer review role/process
📌HemaSphere Scientific Session: Sat 14 June, 15:45 - 16:45
💡Dive into 3 of our cutting-edge biology papers
jancools.bsky.social
Was a nice experience 😊
Reposted by Jan Cools
hemasphere-journal.bsky.social
This study examines the frequency of recurring gene mutations and their interplay with well-known biomarkers in female and male patients, between 18-80 years, with ref/rel DLBCL compared to patients with CR to identify biological risk factors associated with treatment response👉https://bit.ly/4ihynhR
Reposted by Jan Cools
charles-debock.bsky.social
If you are interested in learning about #PDX models in in vivo drug testing, take the time to listen to the following @hemasphere-journal.bsky.social podcast featuring Prof Richard Lock. 👇
kidscancerinst.bsky.social
Prof. Richard Lock featured in HemaSphere podcast discussing his internationally recognised program using PDX models in preclinical testing, to study leukaemia biology and test new treatments in a highly personalised way.
ccia.support/RLpod
jancools.bsky.social
Great podcast! There is a large variety on the quality of preclinical studies and the study discussed here is really top!! Published in @hemasphere-journal.bsky.social
Reposted by Jan Cools
hemasphere-journal.bsky.social
This study quantified Bcl-2 family protein expression in newly diagnosed MM patients. High levels of Bad and Puma proteins were linked to longer OS. Bcl-2 protein ratios predicting venetoclax sensitivity distinguished patients with shorter progression times 👉https://bit.ly/4fUpV6c
Reposted by Jan Cools
hemasphere-journal.bsky.social
We're proud to be fully open access - from day one, in fact.
wiley.com
wiley.com @wiley.com · Jan 29
Open Access makes your research free for anyone to read, use, and build on—boosting innovation and expanding reach. 🚀

👉 Check out our infographic for a quick guide on how #OpenAccess can amplify your work!
jancools.bsky.social
On my way to Prague for their national hematology meeting, with my ‘retro’ EHA bag… this must be very old considering the logo…but still very useful 😊
Reposted by Jan Cools
hemasphere-journal.bsky.social
📢 Authors evaluated the efficacy JPX-0700 and JPX-0750 as dual STAT3/5 inhibitors, reducing leukemic cell growth in AML/NKCL models. These compounds target STAT3/5 signaling, inducing cell death and growth arrest and exhibit synergistic effects w/ approved chemotherapeutics👉https://bit.ly/42oMtJp
Reposted by Jan Cools
hemasphere-journal.bsky.social
2024 has been a successful year for HemaSphere Journal!
 800+ manuscript submissions
 increasing impact in the field
 insightful graphical abstracts
 another podcast season
 ...and of course, excellent research!

We extend a warm thank you to all authors, reviewers & readers ❤️
Reposted by Jan Cools
hemasphere-journal.bsky.social
📖HemaSphere's December issue is now complete 👉https://bit.ly/HS_Dec2024 and as always, is 100% #OpenAccess. Please enjoy reading and feel free to share with your networks.
Reposted by Jan Cools
hemasphere-journal.bsky.social
Microbes support normal blood production! Authors in this recently published article report on the microbes and microbial metabolites missing from pediatric patients with antibiotic-associated neutropenia. @TheKingLab 👉https://bit.ly/4fUXyWe
jancools.bsky.social
It was great to have you in the team!!